Viewing nowAntiFat Tablets (L-Carnitine)
L-Carnitine 330mg
Tablet · OTC medication
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201705505 · Notified 2017.07.10
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
This medication is used for primary and secondary carnitine deficiency and cardiac metabolic disorders caused by ischemic heart disease, such as angina and acute myocardial infarction.
Adults: Administer 2-3 g of L-carnitine per day orally in 2-3 divided doses (take). Adjust the dose as appropriate according to age and symptoms.
This medication should not be used in patients with specific allergic reactions. In particular, patients with hypersensitivity to this medication or allergic to soybean oil, soy, or peanuts should avoid taking it. Patients with lipid metabolism issues, such as hyperlipoproteinemia or diabetic dyslipidemia, and pancreatitis should use this medication with caution. As this medication contains a lipid emulsion, care should be taken when administering it to such patients. Temporary side effects such as nausea, vomiting, abdominal pain, diarrhea, and changes in body odor may occur upon administration. Allergic reactions such as skin rash, urticaria, or facial swelling have also been reported. In patients with impaired renal function, symptoms such as muscle weakness may occur, so caution is required. Patients at high risk of fat overload should check their serum lipid levels before taking this medication. If the excretion of body fat is not smooth, the dosage should be adjusted. If other medications containing lipid components are being used concurrently, the amount of lipid contained in this medication must be taken into consideration for dosage adjustment. Pregnant women or women who may become pregnant should only take this medication when the benefits of treatment outweigh the risks, as its safety has not been established. Also, in the case of breastfeeding, caution should be exercised due to the possibility of this medication being transmitted through breast milk.
Not everyone experiences these, and they can vary from person to person.
This medication should be discussed with a doctor or pharmacist if used with intravenous lipid preparations.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is recommended to keep it at a temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness and prevents deterioration.
White round film-coated tablets
90 tablets (10 tablets/PTP packaging x 9)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowL-Carnitine 330mg
Tablet · OTC medication
Kujoo Pharmaceutical Co., Ltd.
L-Carnitine 200mg
Prescription medication
Albozen Korea Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Seoul Pharmaceutical Co., Ltd.
L-Carnitine 330mg
Tablet · OTC medication
HLB Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Daehan New Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
SS Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Mothers Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.